Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

International Spine Institute's Dr. Marco Rodriguez Using Stem Cell Therapy Instead of Spinal Surgery to Relieve Chronic Low Back Pain

The spine fusion alternative is less invasive, reduces back pain, and potentially can rejuvenate and regenerate the spinal disc.


News provided by

International Spine Institute

Jan 14, 2019, 06:00 ET

Share this article

Share toX

Share this article

Share toX

BATON ROUGE, La., Jan. 14, 2019 /PRNewswire/ -- Marco Rodriguez, MD is a board-certified and fellowship-trained orthopedic spine surgeon and founder of the International Spine Institute. He offers regenerative stem cell therapy instead of spinal surgery to relieve chronic low back pain caused by degenerative disc disease for qualified and select candidates.

Devoted to patient-centered care, Dr. Rodriguez created International Spine Institute in 2015 with the idea of developing a concierge and medical tourism practice that would lead the way in least invasive procedures offering stem cell disc therapy, endoscopic spine surgery, and artificial disc replacement – as alternatives to spinal fusion, which he considers a last-resort surgery.

Estimates show low back pain in the United States to be a $200 billion-dollar problem, with more than 80 percent of the population experiencing low back pain in varying degrees over their lifetime. According to The Rising Prevalence of Chronic Low Back Pain, American businesses are losing money because of lost days of work (nearly 300 million days per year) and lower productivity. Chronic low back pain is the number one cause of disability in most countries, one of the most common reasons for missed work in the United States (more than $253 billion in lost wages) and the second most common reason for doctor visits.

In many cases low back pain is associated with degenerative changes in the spine and the spinal disc. Degenerative disc disease results from normal wear and tear or traumatic injury of one or more spinal discs causing low back pain. Unlike other tissues in the body, the spinal disc has a very low blood supply that provides the necessary nutrients and stem cells needed for regeneration. Once a disc is injured, it does not have the ability to repair itself.

Stem cell therapy is an innovative way to collect stem cells from the bone marrow, process them to isolate the stem cells, and then under fluoroscopic X-ray guidance, a spine surgeon can precisely deliver the stem cells to the affected degenerative disc.

Too often patients suffering from degenerative disc disease, or low back pain, cope with the pain, seek pain management, are prescribed opiate narcotic medications, or are offered spinal fusion as treatment options.

"We are filling the gap between pain management and spinal surgery. Pain management is quite simply short-term relief and has huge risks with regards to opiate narcotic addiction," said Dr. Rodriguez. He adds that "recovery time for minimally invasive spine procedures is 4-6 weeks; spinal fusions are 3-6 months. Often times, patients put up with pain because they are afraid to be out of work that long, which risks further degeneration."

Spinal fusion surgery removes the spinal disc between two or more vertebrae in the spine and the adjacent vertebrae are "fused" by bone grafts and/or metal devices and secured with screws and is performed through the abdomen or back. Spinal fusion, which is the preferred method for most spine doctors, is a very invasive and costly procedure for the patient, and sometimes comes with poor outcomes, not to mention significant risks, long recoveries, and a likely follow-up surgery 15-20 years out.

According to Dr. Rodriguez: "Regenerative stem cell therapy for chronic back pain has been studied and results showed an 80 percent reduction in the rate of spinal fusions for patients who had a spinal fusion recommended. The pain was also reduced significantly and function was improved dramatically."

Stem cell therapy is an excellent alternative to minimally invasive surgery like spinal fusion. Least invasive options, such as stem cell therapy, use a small skin puncture to access the bone marrow and then a needle injection of the stem cells to the disc. Patients are kept comfortable with local anesthetic or conscious IV sedation, experience less pain and return to work and play sooner than minimally invasive spinal fusion surgery.

Stem cell therapy can be an effective treatment for a variety of degenerative spinal conditions, including herniated disc, sciatica, and low back pain. This less invasive procedure is more cost-effective and decreases patient recovery time, quickly getting them back to a pain-free lifestyle without the added risk of opioid dependency. Opioid dependency has become a national epidemic that kills nearly 100 people a day in the United States. Regenerative stem cell therapy is an innovative healing option, which uses the body's own stem cells from bone marrow to treat discogenic low back pain due to degenerative disc diseases by reintroducing them to seal and heal the disc.

Least Invasive Stem Cell Procedure:

  • Outpatient procedure uses local numbing anesthetic or conscious IV sedation
  • No Incisions, small puncture through the skin
  • Minimal pain and discomfort
  • Return to work and active lifestyle as early 1 week
  • Causes less pain and trauma to the back muscles
  • Significant cost reduction for the patient

Watch Dr. Rodriguez explain how it works: https://www.youtube.com/watch?v=pYSaUcSEyGU

After conservative methods have failed, endoscopic spine surgery and regenerative stem cell therapy are spinal fusion alternatives that provide better experiences for the patient all around. "We're just the facilitators," says Dr. Rodriguez. "Helping the body to heal itself. Sometimes the best way to fix something is to put things in place and let the body do all the work."

About International Spine Institute

Based in Baton Rouge, LA, the International Spine Institute specializes in concierge medicine, medical tourism and offering patients least invasive spine procedures featuring stem cell therapy, endoscopic spine surgery and minimally invasive artificial disc replacement. These procedures return patients back to their normal routine quickly, with minimal pain and recovery as possible. We put patients first. Dr. Marco A. Rodriguez and his team strive to listen to patients' needs and provide solutions that restore function, relieve pain and helps patients regain their quality of life.

For more information, visit www.ISpineI.com. Find us on Facebook at facebook.com/Internationalspine and on YouTube at youtube.com/channel/UCIHSC9qRqOTkzuRvYsFVbfg.

Press Contact:

Todd Bouwkamp
Marketing Consultant
[email protected]
225.588.6659

Related Images

marco-rodriguez-md.jpg
Marco Rodriguez, MD
Surgeon meeting with a patient

stem-cell-therapy.jpg
Stem Cell Therapy
Animation of stem cell

Related Links

Low Back Pain

Stem Cell Therapy Overview

Related Video

http://www.youtube.com/watch?v=pYSaUcSEyGU

SOURCE International Spine Institute

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.